# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001640334-24-001787
Filing Date
2024-11-26
Accepted
2024-11-26 13:01:52
Documents
89
Period of Report
2024-08-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K | lxrp_10k.htm iXBRL | 10-K | 1413849
2 | EXECUTIVE EMPLOYMENT | lxrp_ex109.htm | EX-10.9 | 125789
3 | EXECUTIVE EMPLOYMENT | lxrp_ex1010.htm | EX-10.10 | 99550
4 | INSIDER TRADING | lxrp_ex191.htm | EX-19.1 | 42890
5 | SUBSIDIARIES | lxrp_ex211.htm | EX-21.1 | 3406
6 | CONSENT | lxrp_ex231.htm | EX-23.1 | 1692
7 | CERTIFICATION | lxrp_ex311.htm | EX-31.1 | 9370
8 | CERTIFICATION | lxrp_ex312.htm | EX-31.2 | 9602
9 | CERTIFICATION | lxrp_ex321.htm | EX-32.1 | 6243
10 | CERTIFICATION | lxrp_ex322.htm | EX-32.2 | 6259
11 | CLAWBACK POLICY | lxrp_ex971.htm | EX-97.1 | 34112
17 |  | lxrp_ex191img2.jpg | GRAPHIC | 15114
| Complete submission text file | 0001640334-24-001787.txt |  | 6597912

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
12 | XBRL TAXONOMY EXTENSION SCHEMA | lxrp-20240831.xsd | EX-101.SCH | 71426
13 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | lxrp-20240831_lab.xml | EX-101.LAB | 346718
14 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | lxrp-20240831_cal.xml | EX-101.CAL | 50455
15 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | lxrp-20240831_pre.xml | EX-101.PRE | 284348
16 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | lxrp-20240831_def.xml | EX-101.DEF | 136946
92 | EXTRACTED XBRL INSTANCE DOCUMENT | lxrp_10k_htm.xml | XML | 987566

Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-K | Act: 34 | File No.: 001-39874 | Film No.: 241501251
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)